Oracle's Ambitious AI Push Faces Investor Scrutiny Amid Heavy Borrowing Plans

Oracle plans a massive $50B capital raise for AI cloud infrastructure, causing a stock drop and a shareholder lawsuit over disclosure concerns.

Oracle Corporation is preparing for a significant capital raise to fund its aggressive expansion into artificial intelligence infrastructure. The software giant plans to secure up to $50 billion this year, a move that has sparked unease among shareholders. This investor concern manifested in a sharp 5.5% drop in the company's share price last Friday, leaving the stock trading near $148.

Financing a Multi-Billion Dollar Vision

The company's substantial funding requirement stems from major cloud service agreements it has recently secured with several technology leaders, including AMD, Meta, Nvidia, OpenAI, TikTok, and xAI. To deliver the contracted cloud capacity, Oracle must make massive investments in data centers and hardware. For its 2026 fiscal year, the corporation anticipates capital expenditures approaching $50 billion.

In early February, Oracle detailed its strategy to meet these costs. Approximately half of the targeted $45 to $50 billion is expected to come from equity offerings. This includes a program for up to $20 billion and the issuance of convertible preferred shares. The remaining portion will be sourced through debt issuance, with Goldman Sachs and Citigroup coordinating the efforts.

Mounting Legal and Insider Selling Pressures

While the financing plan is ambitious, it is not the only factor giving investors pause. On February 9, CEO Clayton M. Magouyrk sold 10,000 shares at an average price of $155.23, reducing his direct holding to 134,030 shares.

Simultaneously, the law firm Kessler Topaz Meltzer & Check has initiated a class action lawsuit against Oracle. The suit alleges that the company misled investors between June and December 2025 regarding its true capital requirements and near-term revenue prospects. The legal filing points specifically to December quarterly results, which revealed a negative free cash flow exceeding $10 billion and an unexpected $15 billion increase in the investment forecast. The deadline to name a lead plaintiff in this case is April 6, 2026.

The Path Forward for Oracle

Amid these challenges, Oracle has secured a notable contract win. The Centers for Medicare & Medicaid Services have selected the Oracle Cloud Infrastructure, providing at least some positive momentum.

The core question for the market, however, remains whether these enormous investments will translate into proportional revenue growth in the medium term. Trading activity suggests a reevaluation is underway. Last Friday, 29.2 million shares changed hands, a volume 9% above the average, indicating heightened investor deliberation over their positions.